Publicaciones en las que colabora con Zoraida Verde Rello (9)

2012

  1. Acyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: A replication study

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players

    Scandinavian Journal of Medicine and Science in Sports, Vol. 21, Núm. 6

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

  2. ACE and ACTN3 genes and muscle phenotypes in nonagenarians

    International Journal of Sports Medicine, Vol. 31, Núm. 4, pp. 221-224

  3. Are elite endurance athletes genetically predisposed to lower disease risk?

    Physiological Genomics, Vol. 41, Núm. 1, pp. 82-90

  4. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults?

    Scandinavian Journal of Medicine and Science in Sports, Vol. 20, Núm. 5, pp. 771-778

2009

  1. Genotype distributions in top-level soccer players: A role for ace ?

    International Journal of Sports Medicine, Vol. 30, Núm. 5, pp. 387-392

  2. Is there an optimum endurance polygenic profile?

    Journal of Physiology, Vol. 587, Núm. 7, pp. 1527-1534

  3. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593